ConductScience.org, home

Paper37545238

Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology.

Macyczko JR and 9 others. J Alzheimers Dis, 2023. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology. Papers, record 37545238. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37545238

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Upregulation of sFRP1 Is More Profound in Female than Male 5xFAD Mice and Positively Associated with Amyloid Pathology.
PubMed
Journal
J Alzheimers Dis
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
1.26
iCite
Revised in PubMed
2026-01-27
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Macyczko JRJesse R
2Wang NNa
3Lu WWenyan
4Jeevaratnam SSuren
5Shue FFrancis
6Martens YYuka
7Liu CCChia-Chen
8Kanekiyo TTakahisa
9Bu GGuojun
10Li YYonghe

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Amyloid beta-Protein PrecursorMajor topic
Animals
Female
Male
Mice
ADAM10 Protein
Amyloid
Amyloid beta-Peptides
Amyloidogenic Proteins
Aspartic Acid Endopeptidases
Brain
Disease Models, Animal
Mice, Transgenic
Up-Regulation
Secreted Frizzled-Related Proteins

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R21 AG065653NIA NIH HHSUnited StatesR21AG065653PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19343467Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.JAMA1997https://conductscience.org/library/papers/9343467PubMed
215146243A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model.J Clin Invest2004https://conductscience.org/library/papers/15146243PubMed
320619937Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease.Neurobiol Aging2012https://conductscience.org/library/papers/20619937PubMed
410097139Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10097139PubMed
534687956Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review.Ageing Res Rev2021https://conductscience.org/library/papers/34687956PubMed
617021169Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation.J Neurosci2006https://conductscience.org/library/papers/17021169PubMed
719608551Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.Hum Mol Genet2009https://conductscience.org/library/papers/19608551PubMed
830836275ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker.Biomed Pharmacother2019https://conductscience.org/library/papers/30836275PubMed
924650793Exosome reduction in vivo is associated with lower amyloid plaque load in the 5XFAD mouse model of Alzheimer's disease.Neurobiol Aging2014https://conductscience.org/library/papers/24650793PubMed
1029985474Sex differences in Alzheimer disease - the gateway to precision medicine.Nat Rev Neurol2018https://conductscience.org/library/papers/29985474PubMed
1121478884SFRPs act as negative modulators of ADAM10 to regulate retinal neurogenesis.Nat Neurosci2011https://conductscience.org/library/papers/21478884PubMed
1224055016ADAM10 missense mutations potentiate β-amyloid accumulation by impairing prodomain chaperone function.Neuron2013https://conductscience.org/library/papers/24055016PubMed
1320676056ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons.EMBO J2010https://conductscience.org/library/papers/20676056PubMed
1432098349Enhancing α-secretase Processing for Alzheimer's Disease-A View on SFRP1.Brain Sci2020https://conductscience.org/library/papers/32098349PubMed
1527025652The amyloid hypothesis of Alzheimer's disease at 25 years.EMBO Mol Med2016https://conductscience.org/library/papers/27025652PubMed
1636215026Suppression of Wnt/β-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer's Disease.Mol Neurobiol2023https://conductscience.org/library/papers/36215026PubMed
1735115731Large-scale deep multi-layer analysis of Alzheimer's disease brain reveals strong proteomic disease-related changes not observed at the RNA level.Nat Neurosci2022https://conductscience.org/library/papers/35115731PubMed
1821214928APP processing in Alzheimer's disease.Mol Brain2011https://conductscience.org/library/papers/21214928PubMed
1931926610Deep Multilayer Brain Proteomics Identifies Molecular Networks in Alzheimer's Disease Progression.Neuron2020https://conductscience.org/library/papers/31926610PubMed
2035390543The development of ADAM10 endocytosis inhibitors for the treatment of Alzheimer's disease.Mol Ther2022https://conductscience.org/library/papers/35390543PubMed

See all 26 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
42524328Pharmacodynamic and stage-dependent therapeutic efficacy of SFRP1 neutralization in a mouse model of Alzheimer's disease.Alzheimers Dement (N Y)2026https://conductscience.org/library/papers/42524328PubMed
42185674Overexpression of WNT3a in the Hippocampus Can Partly Alleviate Deficits in Animal Models of Alzheimer's Disease.Neurochem Res2026https://conductscience.org/library/papers/42185674PubMed
42146614Discovery of a CI-994 derivative as a dual modulator of class I HDACs and Wnt/β- catenin signaling for Alzheimer's disease therapy.bioRxiv2026https://conductscience.org/library/papers/42146614PubMed
42104459Proteomic analysis in Alzheimer's disease and other dementias: a focus on sex-specific differences.Alzheimers Res Ther2026https://conductscience.org/library/papers/42104459PubMed
41840318Unravelling Epigenetic Modulation via MicroRNA Delivery: A Therapeutic Frontier for Alzheimer's.Mol Neurobiol2026https://conductscience.org/library/papers/41840318PubMed
41654970CI-994 is a dual modulator of class I HDACs and Wnt/β-catenin signaling for the treatment of Alzheimer's disease.Alzheimers Res Ther2026https://conductscience.org/library/papers/41654970PubMed
39447490Amyloid pathology and cognitive impairment in hAβ-KI and APPSAA-KI mouse models of Alzheimer's disease.Neurobiol Aging2025https://conductscience.org/library/papers/39447490PubMed
39269584Activation of the muscle-to-brain axis ameliorates neurocognitive deficits in an Alzheimer's disease mouse model via enhancing neurotrophic and synaptic signaling.Geroscience2025https://conductscience.org/library/papers/39269584PubMed
39167347Age- and Sex-Associated Wnt Signaling Dysregulation is Exacerbated from the Early Stages of Neuropathology in an Alzheimer's Disease Model.Neurochem Res2024https://conductscience.org/library/papers/39167347PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ADAM10102PubTator's text mininghttps://conductscience.org/library/genes/102NCBI Gene
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
SFRP16422PubTator's text mininghttps://conductscience.org/library/genes/6422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37545238

GET https://conductscience.org/api/papers/v1/37545238/references?page=2